Non-invasive Prenatal Test (NIPT)

Constitutional

Non-invasive Prenatal Test (NIPT)

The verifi® from Genetics Associates, Inc. Prenatal Test is a non-invasive test that screens for aneuploidy of chromosomes 21, 18, and 13. Additional screening is available for sex chromosome aneuploidies and select microdeletions in singleton pregnancies. In twin pregnancies, screening for aneuploidy in chromosomes 21, 18, and 13 and the option to screen for the absence of the Y chromosome is available. This test can be performed as early as 10 weeks gestational age (8 weeks of fetal age as determined by date of conception).